1. Home
  2. IDYA vs KNTK Comparison

IDYA vs KNTK Comparison

Compare IDYA & KNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$34.38

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Kinetik Holdings Inc.

KNTK

Kinetik Holdings Inc.

HOLD

Current Price

$36.04

Market Cap

2.5B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
KNTK
Founded
2015
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Natural Gas Distribution
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.5B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
IDYA
KNTK
Price
$34.38
$36.04
Analyst Decision
Strong Buy
Buy
Analyst Count
13
11
Target Price
$49.18
$48.00
AVG Volume (30 Days)
943.7K
1.1M
Earning Date
02-12-2026
11-05-2025
Dividend Yield
N/A
8.72%
EPS Growth
N/A
N/A
EPS
N/A
0.42
Revenue
$214,834,000.00
$1,719,686,000.00
Revenue This Year
$2,662.86
$26.57
Revenue Next Year
N/A
$17.00
P/E Ratio
N/A
$85.96
Revenue Growth
5377.66
18.92
52 Week Low
$13.45
$31.33
52 Week High
$37.08
$67.60

Technical Indicators

Market Signals
Indicator
IDYA
KNTK
Relative Strength Index (RSI) 52.00 53.90
Support Level $33.11 $35.05
Resistance Level $34.45 $35.99
Average True Range (ATR) 1.14 1.14
MACD -0.08 0.11
Stochastic Oscillator 44.14 52.05

Price Performance

Historical Comparison
IDYA
KNTK

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About KNTK Kinetik Holdings Inc.

Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.

Share on Social Networks: